Ginkgo Bioworks Holdings, Inc. (DNA)
8.74
+0.05
(+0.58%)
USD |
NYSE |
May 27, 16:00
8.75
+0.01
(+0.11%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Shareholders Equity (Quarterly) : 443.15M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.908B |
| Inotiv, Inc. | 77.10M |
| Bio-Rad Laboratories, Inc. | 6.851B |
| Bruker Corp. | 2.449B |
| Azenta, Inc. | 1.555B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.033B |
| Total Liabilities (Quarterly) | 589.92M |
| Debt to Equity Ratio | 0.9268 |
| Current Ratio | 5.150 |
| Net Debt Paydown Yield | 3.00% |